It costs about $7,000 per year to treat someone who has MDR-TB, which is about 100 times the cost of treating drug-sensitive TB, he said, adding that "there was still an urgency to allocate more money" for MDR-TB. "If we can do it for H1N1, we can do it for TB. These epidemics have been at (pandemic) level 6 plus plus plus plus for years," Kazatchkine said (Lyn, 8/10).

This article is republished with kind permission from our friends at The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is published for Kaisernetwork, a free service of The Henry J. Kaiser Family Foundation. 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.